Headlines Expert Newsletters Covid-19 Specialties Trending Feeds Videos

Mashup Score: 212

Wall Street Journal

The Biden administration’s push to introduce widespread vaccine boosters hit a roadblock at a Food and Drug Administration advisory panel, which could still consider a narrower recommendation.

  • Initial Vote By FDA Advisory Panel Fails to Recommend Covid-19 Booster Doses for People 16 Years and Older